Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Risedronate and Parathyroid Hormone Reverse Glucocorticoid Induced Osteoporosis?

NCT00221299 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT00221299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00221299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Risedronate and Parathyroid Hormone Reverse Glucocorticoid Induced Osteoporosis?
Lead sponsor
University of California, Davis
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2005
Completion date
May 31, 2009
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis